China, India and the political economy of medical supplies

Abstract

• The pandemic and lockdowns threaten the supply of medicines, especially from India • Poor countries relying on supplies of cheap Indian medicines are especially vulnerable • New medicines and vaccines are likely to be developed and patented by Western companies and will be expensive. • Norway should help fund the supply of medicines and promote reforms of patent rules to make medicines more affordable ; publishedVersion